This inventor holds 1 USPTO granted patent. Top assignee: Kagoshima University. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Akio Ido: Innovator in Pharmaceutical Composition
Introduction
Akio Ido is a notable inventor based in Kagoshima, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment and prevention of esophageal stenosis. His innovative work has led to the development of a unique pharmaceutical composition that utilizes HGF protein as an active ingredient.
Latest Patents
Akio Ido holds a patent for a pharmaceutical composition aimed at treating and/or preventing esophageal stenosis. This composition includes an HGF protein, which can be a polypeptide with specific amino acid sequences. The patent outlines various forms of the HGF protein, including those with deletions, substitutions, or additions to the amino acid sequence, as well as polypeptides with at least 90% identity to the specified sequence. Additionally, the patent includes a stent that incorporates this pharmaceutical composition.
Career Highlights
Ido is affiliated with Kagoshima University, where he has been involved in research and development in the pharmaceutical field. His work has garnered attention for its potential impact on treating esophageal conditions, showcasing his dedication to advancing medical science.
Collaborations
Some of Akio Ido's notable coworkers include Hirohito Tsubouchi and Yuga Komaki. Their collaborative efforts contribute to the innovative research environment at Kagoshima University.
Conclusion
Akio Ido's contributions to pharmaceutical innovation, particularly in the treatment of esophageal stenosis, highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in medical treatments.